BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Obesity
,
Stem cell
,
Hematopoietic cell
,
Phenobarbital
,
rs4950928
,
TGFB1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
b cell cll- lymphoma
Summary
General Info
Curated Studies
Most Correlated Studies
CD4+ cells from patients with different neoplasms - gene expression in response to activation
Mantle Cell Lymphoma - gene expression patterns of indolent and conventional disease
B-cell chronic lymphocytic leukemia (B-CLL) cells expression profiles
Gene expression in chronic lymphocytic leukemia (CLL) cells treated with LMP-420
B-cell chronic lymphocytic leukemia (B-CLL) cells miRNA expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
BCL10 loss-of-function novel mutation leading to atypical severe combined immunodeficiency.
BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine.
Clinical and Immunological Features of Human BCL10 Deficiency.
Primary pure pancreatic-type acinar cell carcinoma of the stomach.
BCL10 regulates the production of proinflammatory cytokines by activating MAPK-NF-κB/Rel signaling p…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL
Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL
Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL
Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL
Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphom…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ